Understanding Alzheimer's disease in African Americans
Official title: Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease
Funded at University of Miami School of Medicine · NIH-11041129 · Data updated 2026-11-12
This study is all about helping African American older adults by finding better ways to detect Alzheimer's disease early, using special tests that fit their health needs, and making it easy for them to participate from home or with transportation for important scans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project start | June 1, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $1,541,121 |
| NIH project number | 5R01AG077677-03 |
| Project ID | NIH-11041129 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African American older adults who are at risk for Alzheimer's disease or related disorders.
✕Less likely to help
Patients who are not African American or those who do not have a risk for Alzheimer's disease may not benefit from this research.
What this research studies
This research focuses on improving the understanding and early detection of Alzheimer's disease and related disorders specifically in African American older adults. It aims to address the significant under-representation of this population in clinical research by employing innovative cognitive and biomarker assessments tailored to their unique health profiles. The study will utilize home-based assessments and provide transportation for necessary imaging studies, making participation more accessible. By deeply phenotyping African Americans, the research seeks to enhance the diagnostic and prognostic capabilities of biomarkers associated with Alzheimer's disease.
Why it matters
Potential benefit: If successful, this research could lead to better early detection and tailored therapeutic approaches for Alzheimer's disease in African American populations.
How similar studies have gone: Other research has shown success in using home-based assessments and culturally tailored approaches to engage diverse populations in Alzheimer's research.
Where this research is happening
-
University of Miami School of Medicine
Coral Gables, United States Active
Researchers
- Principal investigator: Loewenstein, David — University of Miami School of Medicine
- Study coordinator: Loewenstein, David
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
CLU's role in Alzheimer's disease pathogenesis
Researchers are studying how the CLU gene may drive brain changes in Alzheimer's disease and how targeting CLU could lead to safer treatments.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.